Literature DB >> 19911257

Cross-interaction chromatography: a rapid method to identify highly soluble monoclonal antibody candidates.

Steven A Jacobs1, Sheng-Jiun Wu, Yiqing Feng, Deidra Bethea, Karyn T O'Neil.   

Abstract

PURPOSE: To develop a high-throughput cross-interaction chromatography screening method to rapidly identify antibody candidates with poor solubility using microgram quantities of purified material.
METHODS: A specific recombinant antibody or bulk polyclonal IgG purified from human serum was chemically coupled to an NHS-activated chromatography resin. The retention times of numerous monoclonal antibodies were determined on this resin using an HPLC and compared to the solubility of each antibody estimated by ultrafiltration.
RESULTS: Retention times of the antibodies tested were found to be inversely related to solubility, with antibodies prone to precipitate at low concentrations in PBS being retained longer on the columns with broader peaks. The technique was successfully used to screen microgram quantities of a panel of therapeutic antibodies to identify candidates with low solubility in PBS.
CONCLUSIONS: The cross-interaction chromatography methods described can be used to screen large panels of recombinant antibodies in order to discover those with low solubility. Addition of this tool to the array of tools available for characterization of affinity and activity of antibody therapeutic candidates will improve selection of candidates with biophysical properties favorable to development of high concentration antibody formulations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19911257     DOI: 10.1007/s11095-009-0007-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

1.  Rapid measurement of protein osmotic second virial coefficients by self-interaction chromatography.

Authors:  Peter M Tessier; Abraham M Lenhoff; Stanley I Sandler
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

Review 2.  Large antibody display libraries for isolation of high-affinity antibodies.

Authors:  Michael M Ling
Journal:  Comb Chem High Throughput Screen       Date:  2003-08       Impact factor: 1.339

Review 3.  Challenges in the development of high protein concentration formulations.

Authors:  Steven J Shire; Zahra Shahrokh; Jun Liu
Journal:  J Pharm Sci       Date:  2004-06       Impact factor: 3.534

4.  Monoclonal antibodies market.

Authors:  Janice Reichert; Alex Pavolu
Journal:  Nat Rev Drug Discov       Date:  2004-05       Impact factor: 84.694

5.  Direct measurement of protein osmotic second virial cross coefficients by cross-interaction chromatography.

Authors:  Peter M Tessier; Stanley I Sandler; Abraham M Lenhoff
Journal:  Protein Sci       Date:  2004-04-09       Impact factor: 6.725

6.  High concentration formulation feasibility of human immunoglubulin G for subcutaneous administration.

Authors:  Bhas Dani; Robert Platz; Stelios T Tzannis
Journal:  J Pharm Sci       Date:  2007-06       Impact factor: 3.534

7.  Kinetic screening of antibody-Im7 conjugates by capture on a colicin E7 DNase domain using optical biosensors.

Authors:  Ralf J Hosse; Leigh Tay; Meghan K Hattarki; Luisa Pontes-Braz; Lesley A Pearce; Stewart D Nuttall; Olan Dolezal
Journal:  Anal Biochem       Date:  2008-11-27       Impact factor: 3.365

8.  Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group.

Authors:  K N Subramanian; L E Weisman; T Rhodes; R Ariagno; P J Sánchez; J Steichen; L B Givner; T L Jennings; F H Top; D Carlin; E Connor
Journal:  Pediatr Infect Dis J       Date:  1998-02       Impact factor: 2.129

9.  Determination of the apparent thermodynamic activities of saturated protein solutions.

Authors:  C R Middaugh; W A Tisel; R N Haire; A Rosenberg
Journal:  J Biol Chem       Date:  1979-01-25       Impact factor: 5.157

10.  Application of phage display to high throughput antibody generation and characterization.

Authors:  Darren J Schofield; Anthony R Pope; Veronica Clementel; Jenny Buckell; Susan Dj Chapple; Kay F Clarke; Jennie S Conquer; Anna M Crofts; Sandra R E Crowther; Michael R Dyson; Gillian Flack; Gareth J Griffin; Yvette Hooks; William J Howat; Anja Kolb-Kokocinski; Susan Kunze; Cecile D Martin; Gareth L Maslen; Joanne N Mitchell; Maureen O'Sullivan; Rajika L Perera; Wendy Roake; S Paul Shadbolt; Karen J Vincent; Anthony Warford; Wendy E Wilson; Jane Xie; Joyce L Young; John McCafferty
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  32 in total

1.  High throughput detection of antibody self-interaction by bio-layer interferometry.

Authors:  Tingwan Sun; Felicia Reid; Yuqi Liu; Yuan Cao; Patricia Estep; Claire Nauman; Yingda Xu
Journal:  MAbs       Date:  2013-08-19       Impact factor: 5.857

Review 2.  Drugs derived from phage display: from candidate identification to clinical practice.

Authors:  Andrew E Nixon; Daniel J Sexton; Robert C Ladner
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

3.  A novel screening method to assess developability of antibody-like molecules.

Authors:  Neeraj Kohli; Nidhi Jain; Melissa L Geddie; Maja Razlog; Lihui Xu; Alexey A Lugovskoy
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 4.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

5.  In vitro and in silico assessment of the developability of a designed monoclonal antibody library.

Authors:  Adriana-Michelle Wolf Pérez; Pietro Sormanni; Jonathan Sonne Andersen; Laila Ismail Sakhnini; Ileana Rodriguez-Leon; Jais Rose Bjelke; Annette Juhl Gajhede; Leonardo De Maria; Daniel E Otzen; Michele Vendruscolo; Nikolai Lorenzen
Journal:  MAbs       Date:  2019-01-18       Impact factor: 5.857

6.  Biophysical properties of the clinical-stage antibody landscape.

Authors:  Tushar Jain; Tingwan Sun; Stéphanie Durand; Amy Hall; Nga Rewa Houston; Juergen H Nett; Beth Sharkey; Beata Bobrowicz; Isabelle Caffry; Yao Yu; Yuan Cao; Heather Lynaugh; Michael Brown; Hemanta Baruah; Laura T Gray; Eric M Krauland; Yingda Xu; Maximiliano Vásquez; K Dane Wittrup
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

7.  Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.

Authors:  Juan Carlos Almagro; Gary L Gilliland; Felix Breden; Jamie K Scott; Devin Sok; Matthias Pauthner; Janice M Reichert; Gustavo Helguera; Raiees Andrabi; Robert Mabry; Mathieu Bléry; James E Voss; Juha Laurén; Lubna Abuqayyas; Stefan Barghorn; Eshel Ben-Jacob; James E Crowe; James S Huston; Stephen Albert Johnston; Eric Krauland; Fridtjof Lund-Johansen; Wayne A Marasco; Paul W H I Parren; Kai Y Xu
Journal:  MAbs       Date:  2014-03-03       Impact factor: 5.857

8.  High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy.

Authors:  Yuqi Liu; Isabelle Caffry; Jiemin Wu; Steven B Geng; Tushar Jain; Tingwan Sun; Felicia Reid; Yuan Cao; Patricia Estep; Yao Yu; Maximiliano Vásquez; Peter M Tessier; Yingda Xu
Journal:  MAbs       Date:  2013-12-06       Impact factor: 5.857

9.  Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering.

Authors:  James C Geoghegan; Ryan Fleming; Melissa Damschroder; Steven M Bishop; Hasige A Sathish; Reza Esfandiary
Journal:  MAbs       Date:  2016-04-06       Impact factor: 5.857

10.  Target-independent variable region mediated effects on antibody clearance can be FcRn independent.

Authors:  Ryan L Kelly; Yao Yu; Tingwan Sun; Isabelle Caffry; Heather Lynaugh; Michael Brown; Tushar Jain; Yingda Xu; K Dane Wittrup
Journal:  MAbs       Date:  2016-09-09       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.